FDA Inspection 1093699 — Reviva Labs Inc
The FDA completed an inspection of Reviva Labs Inc on June 21, 2019 in Haddonfield, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). 1 citation was issued during this inspection. Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 21, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Haddonfield, NJ (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 16495 | FDCA 601(c) | Insanitary conditions; injurious to health |